loadpatents
Patent applications and USPTO patent grants for Krauss; Nancy Elisabeth.The latest application filed is for "indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists".
Patent | Date |
---|---|
Indole, Indazole And Benzimidazole Arylamides As P2x3 And P2x2/3 Antagonists App 20160362395 - Dillon; Michael Patrick ;   et al. | 2016-12-15 |
Indole, indazole and benzimidazole arylamides as P2X.sub.3 and P2X.sub.2/3 antagonists Grant 9,440,956 - Dillon , et al. September 13, 2 | 2016-09-13 |
Indole, indazole and benzimidazole arylamides as P2X.sub.3 and P2X.sub.2/3 antagonists Grant 8,476,457 - Dillon , et al. July 2, 2 | 2013-07-02 |
Dihydropyridone amides as P2X.sub.7 modulators Grant 8,372,865 - Berger , et al. February 12, 2 | 2013-02-12 |
Indole, Indazole And Benzimidazole Arylamides As P2x3 And P2x2/3 Antagonists App 20100324070 - Dillon; Michael Patrick ;   et al. | 2010-12-23 |
Chroman derivatives and uses thereof Grant 7,759,389 - Krauss , et al. July 20, 2 | 2010-07-20 |
Dihydropyridone Amides As P2x7 Modulators App 20100160373 - Berger; Jacob ;   et al. | 2010-06-24 |
Tetralin and indane derivatives and uses thereof Grant 7,576,103 - Harris, III , et al. August 18, 2 | 2009-08-18 |
Chroman derivatives and uses thereof Grant 7,528,250 - Krauss , et al. May 5, 2 | 2009-05-05 |
Tetralin and indane derivatives and uses thereof Grant 7,473,690 - Harris, III , et al. January 6, 2 | 2009-01-06 |
Quinazolinone and benzoxazinone derivatives and uses thereof Grant 7,365,063 - Krauss , et al. April 29, 2 | 2008-04-29 |
Benzamide nitriles Grant 7,300,934 - Gabriel , et al. November 27, 2 | 2007-11-27 |
Quinazolinone and benzoxazinone derivatives and uses thereof App 20070149510 - Krauss; Nancy Elisabeth ;   et al. | 2007-06-28 |
Quinazolinone and benzoxazinone derivatives and uses thereof Grant 7,196,087 - Krauss , et al. March 27, 2 | 2007-03-27 |
P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents App 20060173075 - Krauss; Nancy Elisabeth ;   et al. | 2006-08-03 |
Tetralin and indane derivatives and uses thereof App 20060160825 - Harris; Ralph New III ;   et al. | 2006-07-20 |
Tetralin and indane derivatives and uses thereof App 20060154965 - Harris; Ralph New III ;   et al. | 2006-07-13 |
Chroman derivatives and uses thereof App 20060148888 - Krauss; Nancy Elisabeth ;   et al. | 2006-07-06 |
Chroman derivatives and uses thereof App 20060148820 - Krauss; Nancy Elisabeth ;   et al. | 2006-07-06 |
P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents Grant 7,071,177 - Krauss , et al. July 4, 2 | 2006-07-04 |
Quinazolinone and benzoxazinone derivatives and uses thereof App 20050165001 - Krauss, Nancy Elisabeth ;   et al. | 2005-07-28 |
Benzamide nitriles App 20040248949 - Gabriel, Tobias ;   et al. | 2004-12-09 |
Indole nitriles Grant 6,759,428 - Bamberg , et al. July 6, 2 | 2004-07-06 |
Heteroaryl nitriles Grant 6,747,053 - Gabriel , et al. June 8, 2 | 2004-06-08 |
Indole nitriles App 20040077646 - Bamberg, Joe Timothy ;   et al. | 2004-04-22 |
Heteroaryl nitriles App 20030212097 - Gabriel, Tobias ;   et al. | 2003-11-13 |
p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents App 20020052349 - Krauss, Nancy Elisabeth ;   et al. | 2002-05-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.